Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV-2 infection

Respirology. 2020 Aug;25(8):797-799. doi: 10.1111/resp.13875. Epub 2020 Jun 17.

Authors

Tomas Raul Wiche Salinas^{1

2}, Boyang Zheng³, Jean-Pierre Routy⁴, Petronela Ancuta^{1

2}

Affiliations

¹ CHUM-Research Centre, Montréal, QC, Canada.
² Département de microbiologie, infectiologie et immunologie, Faculté de médecine, Université de Montréal, Montréal, QC, Canada.
³ Division of Rheumatology, McGill University Health Centre, McGill University, Montréal, QC, Canada.
⁴ Chronic Viral Illness Service and Division of Hematology, McGill University Health Centre, Montréal, QC, Canada.

No abstract available

Keywords: COVID-19; acute respiratory distress syndrome; cytokine.

Grants and funding